Other baseline characteristics of the patients enrolled in the study included Nottingham grade of cancer, type of anthracycline, number of anthracycline cycles, therapeutics administered as the second part of the adjuvant program, blood relatives with cancer, marital status, diabetes, dyslipidemia and ER, PR and Her-2 receptor status are also presented as percentage frequencies in Table 2 [22]. A summary of the echocardiographic analysis is presented in Fig. 2 [22]. The gene discussed is PGR; the disease is metabolic syndrome.